GILD Gilead Sciences | 6/1/2026 | Reiterated Rating | $134.43 | $122.00 | Overweight | $0.00 00.00% ROI | |
GILD Gilead Sciences | 6/1/2026 | Upgrade | $131.10 | | Moderate Buy | $0.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 5/29/2026 | Boost Price Target | $157.47 | $183.00 | Outperform | $0.00 00.00% ROI | |
BIIB Biogen | 5/27/2026 | Boost Price Target | $193.08 | $227.00 | Outperform | $0.00 00.00% ROI | |
REGN Regeneron Pharmaceuticals | 5/18/2026 | Lower Price Target | $623.32 | $707.00 | Sector Perform | $0.00 00.00% ROI | |
GILD Gilead Sciences | 5/8/2026 | Lower Price Target | $130.55 | $122.00 | Sector Perform | $0.00 00.00% ROI | |
PTCT PTC Therapeutics | 5/8/2026 | Boost Price Target | $79.08 | $82.00 | Sector Perform | $0.00 00.00% ROI | |
XENE Xenon Pharmaceuticals | 5/8/2026 | Boost Price Target | $55.89 | $82.00 | Outperform | $0.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 5/6/2026 | Boost Price Target | $144.90 | $180.00 | Outperform | $0.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 5/5/2026 | Boost Price Target | $429.85 | $543.00 | Outperform | $0.00 00.00% ROI | |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
BIIB Biogen | 4/30/2026 | Boost Price Target | $191.32 | $222.00 | Outperform | $0.00 00.00% ROI | |
REGN Regeneron Pharmaceuticals | 4/30/2026 | Lower Price Target | $707.09 | $762.00 | Sector Perform | $0.00 00.00% ROI | |
BIIB Biogen | 4/29/2026 | Boost Price Target | $191.58 | $222.00 | Outperform | $0.00 00.00% ROI | |
DMRA Damora Therapeutics, Inc. Common Stock | 4/24/2026 | Initiated Coverage | $25.42 | $40.00 | Outperform | $0.00 00.00% ROI | |
DMRA Damora Therapeutics, Inc. Common Stock | 4/23/2026 | Upgrade | $24.75 | | Moderate Buy | $0.00 00.00% ROI | |
EVMN Evommune | 4/10/2026 | Reiterated Rating | $27.56 | $48.00 | Outperform | $0.00 00.00% ROI | |
PHVS Pharvaris | 4/6/2026 | Lower Price Target | $28.56 | $51.00 | Outperform | $0.00 00.00% ROI | |
PHVS Pharvaris | 3/9/2026 | Initiated Coverage | $26.63 | $52.00 | Outperform | $0.00 00.00% ROI | |
APGE Apogee Therapeutics | 3/2/2026 | Lower Price Target | $70.92 | $82.00 | Sector Perform | $0.00 00.00% ROI | |
AARD Aardvark Therapeutics | 3/2/2026 | Downgrade | $12.49 | $6.00 | Sector Perform | $0.00 00.00% ROI | |
REGN Regeneron Pharmaceuticals | 3/2/2026 | Boost Price Target | $784.09 | $765.00 | Sector Perform | $0.00 00.00% ROI | |
MLTX MoonLake Immunotherapeutics | 3/2/2026 | Boost Price Target | $17.69 | $13.00 | Sector Perform | $0.00 00.00% ROI | |
KYMR Kymera Therapeutics | 2/26/2026 | Reiterated Rating | $91.56 | $108.00 | Outperform | $0.00 00.00% ROI | |
ACAD ACADIA Pharmaceuticals | 2/26/2026 | Lower Price Target | $24.82 | $30.00 | Outperform | $0.00 00.00% ROI | |
LKFT Lakefront Biotherapeutics American Depositary Shares | 2/24/2026 | Boost Price Target | $34.36 | $33.00 | Sector Perform | $0.00 00.00% ROI | |
PTCT PTC Therapeutics | 2/20/2026 | Lower Price Target | $69.90 | $82.00 | Sector Perform | $0.00 00.00% ROI | |
MLTX MoonLake Immunotherapeutics | 2/20/2026 | Boost Price Target | $17.86 | $12.00 | Sector Perform | $0.00 00.00% ROI | |
PRTA Prothena | 2/20/2026 | Boost Price Target | $8.83 | $12.00 | Sector Perform | $0.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 2/13/2026 | Lower Price Target | $496.69 | $541.00 | Outperform | $0.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 2/12/2026 | Lower Price Target | $126.01 | $177.00 | Outperform | $0.00 00.00% ROI | |
GILD Gilead Sciences | 2/11/2026 | Boost Price Target | $156.39 | $118.00 | Sector Perform | $0.00 00.00% ROI | |
INCY Incyte | 2/11/2026 | Lower Price Target | $98.59 | $92.00 | Sector Perform | $0.00 00.00% ROI | |
BIIB Biogen | 2/9/2026 | Boost Price Target | $201.18 | $233.00 | Outperform | $0.00 00.00% ROI | |
ACAD ACADIA Pharmaceuticals | 2/3/2026 | Lower Price Target | $26.13 | $31.00 | Outperform | $0.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 1/30/2026 | Lower Price Target | $6.44 | $13.00 | Outperform | $0.00 00.00% ROI | |
NRIX Nurix Therapeutics | 1/29/2026 | Boost Price Target | $17.60 | $30.00 | Outperform | $0.00 00.00% ROI | |
GHRS GH Research | 1/23/2026 | Boost Price Target | $16.46 | $40.00 | Outperform | $0.00 00.00% ROI | |
DFTX Definium Therapeutics | 1/23/2026 | Boost Price Target | $17.29 | $36.00 | Outperform | $0.00 00.00% ROI | |
APGE Apogee Therapeutics | 1/22/2026 | Downgrade | $81.91 | $83.00 | Sector Perform | $0.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 1/22/2026 | Upgrade | $461.14 | $546.00 | Outperform | $0.00 00.00% ROI | |
How to claim a stake in SpaceX before the June 12 IPO (Ad) SpaceX is expected to go public on June 12 - and for the first time, everyday investors may have a way in before the IPO.
Jeff Brown, who identified Bitcoin, Tesla, and Nvidia before gains as high as 52,400%, 2,150%, and 32,000% respectively, is sharing the details on how to claim a stake in Elon Musk's company before it hits public markets. See exactly how to position yourself in SpaceX before June 12 |
GILD Gilead Sciences | 1/20/2026 | Boost Price Target | $124.91 | $103.00 | Sector Perform | $0.00 00.00% ROI | |
BIIB Biogen | 1/13/2026 | Reiterated Rating | $178.30 | | Outperform | $0.00 00.00% ROI | |
GILD Gilead Sciences | 1/8/2026 | Lower Price Target | $121.35 | $100.00 | Sector Perform | $0.00 00.00% ROI | |
SRPT Sarepta Therapeutics | 1/8/2026 | Boost Price Target | $21.31 | $18.00 | Sector Perform | $0.00 00.00% ROI | |
APGE Apogee Therapeutics | 1/6/2026 | Reiterated Rating | $78.59 | | Outperform | $0.00 00.00% ROI | |
KYMR Kymera Therapeutics | 12/16/2025 | Boost Price Target | $85.68 | $103.00 | Outperform | $0.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 12/8/2025 | Boost Price Target | $159.46 | $180.00 | Outperform | $0.00 00.00% ROI | |
PTCT PTC Therapeutics | 12/1/2025 | Downgrade | $85.99 | $91.00 | Sector Perform | $0.00 00.00% ROI | |
NMRA Neumora Therapeutics | 12/1/2025 | Upgrade | $2.26 | $7.00 | Outperform | $0.00 00.00% ROI | |
SION Sionna Therapeutics | 12/1/2025 | Reiterated Rating | $43.57 | $24.00 | Underperform | $0.00 00.00% ROI | |
CTNM Contineum Therapeutics | 11/21/2025 | Lower Price Target | $11.08 | $22.00 | Outperform | $0.00 00.00% ROI | |
CDTX Cidara Therapeutics | 11/17/2025 | Downgrade | $217.78 | | Sector Perform | $0.00 00.00% ROI | |
AARD Aardvark Therapeutics | 11/14/2025 | Lower Price Target | $10.86 | $18.00 | Outperform | $0.00 00.00% ROI | |
CRBP Corbus Pharmaceuticals | 11/13/2025 | Lower Price Target | $11.09 | $53.00 | Outperform | $0.00 00.00% ROI | |
PRTA Prothena | 11/7/2025 | Boost Price Target | $10.15 | $11.00 | Sector Perform | $0.00 00.00% ROI | |
DFTX Definium Therapeutics | 11/7/2025 | Lower Price Target | $11.26 | $20.00 | Outperform | $0.00 00.00% ROI | |
LKFT Lakefront Biotherapeutics American Depositary Shares | 11/7/2025 | Boost Price Target | $31.38 | $32.00 | Sector Perform | $0.00 00.00% ROI | |
CDTX Cidara Therapeutics | 11/7/2025 | Boost Price Target | $99.95 | $145.00 | Outperform | $0.00 00.00% ROI | |
ACAD ACADIA Pharmaceuticals | 11/6/2025 | Lower Price Target | $21.35 | $32.00 | Outperform | $0.00 00.00% ROI | |
PTCT PTC Therapeutics | 11/5/2025 | Boost Price Target | $72.90 | $82.00 | Outperform | $0.00 00.00% ROI | |
XENE Xenon Pharmaceuticals | 11/4/2025 | Boost Price Target | $39.54 | $58.00 | Outperform | $0.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 11/4/2025 | Lower Price Target | $430.41 | $415.00 | Sector Perform | $0.00 00.00% ROI | |
KPTI Karyopharm Therapeutics | 11/4/2025 | Lower Price Target | $5.66 | $19.00 | Outperform | $0.00 00.00% ROI | |
APGE Apogee Therapeutics | 11/3/2025 | Boost Price Target | $57.13 | $70.00 | Outperform | $0.00 00.00% ROI | |
BIIB Biogen | 10/31/2025 | Lower Price Target | $149.61 | $210.00 | Outperform | $0.00 00.00% ROI | |
GILD Gilead Sciences | 10/31/2025 | Boost Price Target | $120.73 | $105.00 | Sector Perform | $0.00 00.00% ROI | |
INCY Incyte | 10/29/2025 | Boost Price Target | $89.19 | $84.00 | Sector Perform | $0.00 00.00% ROI | |
REGN Regeneron Pharmaceuticals | 10/29/2025 | Boost Price Target | $654.96 | $708.00 | Sector Perform | $0.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 10/29/2025 | Boost Price Target | $139.82 | $160.00 | Outperform | $0.00 00.00% ROI | |
LKFT Lakefront Biotherapeutics American Depositary Shares | 10/22/2025 | Boost Price Target | $32.33 | $28.00 | Sector Perform | $0.00 00.00% ROI | |
BIIB Biogen | 10/8/2025 | Lower Price Target | $152.21 | $217.00 | Outperform | $0.00 00.00% ROI | |
GILD Gilead Sciences | 10/8/2025 | Boost Price Target | $116.78 | $100.00 | Sector Perform | $0.00 00.00% ROI | |
SRPT Sarepta Therapeutics | 10/8/2025 | Boost Price Target | $24.02 | $16.00 | Sector Perform | $0.00 00.00% ROI | |
MLTX MoonLake Immunotherapeutics | 9/29/2025 | Reiterated Rating | $6.86 | $10.00 | Sector Perform | $0.00 00.00% ROI | |
APGE Apogee Therapeutics | 9/25/2025 | Initiated Coverage | $38.42 | $60.00 | Outperform | $0.00 00.00% ROI | |
CDTX Cidara Therapeutics | 9/24/2025 | Set Price Target | $88.16 | $137.00 | Outperform | $0.00 00.00% ROI | |
INCY Incyte | 9/24/2025 | Boost Price Target | $84.54 | $81.00 | Sector Perform | $0.00 00.00% ROI | |
KYMR Kymera Therapeutics | 9/16/2025 | Initiated Coverage | $47.28 | $70.00 | Outperform | $0.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 9/5/2025 | Boost Price Target | $143.76 | $149.00 | Outperform | $0.00 00.00% ROI | |
SION Sionna Therapeutics | 9/3/2025 | Initiated Coverage | $25.39 | $22.00 | Sector Perform | $0.00 00.00% ROI | |
XENE Xenon Pharmaceuticals | 9/2/2025 | Reiterated Rating | $39.12 | $55.00 | Outperform | $0.00 00.00% ROI | |
AARD Aardvark Therapeutics | 8/14/2025 | Lower Price Target | $11.44 | $19.00 | Outperform | $0.00 00.00% ROI | |
XENE Xenon Pharmaceuticals | 8/12/2025 | Lower Price Target | $36.96 | $55.00 | Outperform | $0.00 00.00% ROI | |
PTCT PTC Therapeutics | 8/8/2025 | Reiterated Rating | $46.87 | $63.00 | Outperform | $0.00 00.00% ROI | |
ETNB 89BIO | 8/8/2025 | Lower Price Target | $8.92 | $11.00 | Sector Perform | $0.00 00.00% ROI | |
GILD Gilead Sciences | 8/8/2025 | Boost Price Target | $119.21 | $98.00 | Sector Perform | $0.00 00.00% ROI | |
ACAD ACADIA Pharmaceuticals | 8/7/2025 | Boost Price Target | $23.84 | $40.00 | Outperform | $0.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 8/5/2025 | Lower Price Target | $389.93 | $405.00 | Sector Perform | $0.00 00.00% ROI | |
PRTA Prothena | 8/5/2025 | Lower Price Target | $7.28 | $10.00 | Sector Perform | $0.00 00.00% ROI | |
REGN Regeneron Pharmaceuticals | 8/4/2025 | Boost Price Target | $569.71 | $695.00 | Sector Perform | $0.00 00.00% ROI | |
The cat is out the bag (Ad) Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered separation packages to 8,500 workers, and Oracle is reportedly eliminating up to 30,000 positions. Goldman Sachs estimates 12,400 Americans are being financially displaced every single day.
Analyst Porter Stansberry says the real driver runs deeper than AI - and two Nobel Prize winners have issued the same warning. He calls it the Final Displacement, and he's releasing a full investigation with specific companies to buy and sell before the next wave hits. Watch Porter Stansberry's full investigation into the Final Displacement now |
BIIB Biogen | 8/1/2025 | Boost Price Target | $126.28 | $219.00 | Outperform | $0.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 7/31/2025 | Lower Price Target | $129.41 | $144.00 | Outperform | $0.00 00.00% ROI | |
INCY Incyte | 7/30/2025 | Boost Price Target | $77.88 | $72.00 | Sector Perform | $0.00 00.00% ROI | |
SRPT Sarepta Therapeutics | 7/17/2025 | Lower Price Target | $21.46 | $23.00 | Sector Perform | $0.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 6/30/2025 | Reiterated Rating | $9.23 | $13.00 | Outperform | $0.00 00.00% ROI | |
BIIB Biogen | 6/25/2025 | Set Price Target | $126.16 | $213.00 | Outperform | $0.00 00.00% ROI | |
CDTX Cidara Therapeutics | 6/24/2025 | Upgrade | $49.86 | $75.00 | Moderate Buy | $0.00 00.00% ROI | |
ACAD ACADIA Pharmaceuticals | 6/23/2025 | Boost Price Target | $22.12 | $38.00 | Outperform | $0.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 6/17/2025 | Set Price Target | $448.47 | $420.00 | Sector Perform | $0.00 00.00% ROI | |
REGN Regeneron Pharmaceuticals | 5/27/2025 | Reiterated Rating | $599.20 | $662.00 | Sector Perform | $000.00 00.00% ROI | |
CTNM Contineum Therapeutics | 5/15/2025 | Reiterated Rating | $3.72 | $31.00 | Outperform | $00.00 00.00% ROI | |
KPTI Karyopharm Therapeutics | 5/13/2025 | Lower Price Target | $5.40 | $33.00 | Outperform | $0.00 00.00% ROI | |
XENE Xenon Pharmaceuticals | 5/13/2025 | Lower Price Target | $29.93 | $55.00 | Outperform | $00.00 00.00% ROI | |
CRBP Corbus Pharmaceuticals | 5/7/2025 | Lower Price Target | $6.34 | $58.00 | Outperform | $00.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 5/6/2025 | Boost Price Target | $434.64 | $423.00 | Sector Perform | $000.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 5/6/2025 | Reiterated Rating | $10.40 | $13.00 | Outperform | $0.00 00.00% ROI | |
BIIB Biogen | 5/2/2025 | Lower Price Target | $122.38 | $205.00 | Outperform | $000.00 00.00% ROI | |
INCY Incyte | 4/30/2025 | Boost Price Target | $61.11 | $67.00 | Sector Perform | $00.00 00.00% ROI | |
REGN Regeneron Pharmaceuticals | 4/30/2025 | Lower Price Target | $586.51 | $943.00 | Outperform | $000.00 00.00% ROI | |
LEGN Legend Biotech | 4/22/2025 | Reiterated Rating | $33.48 | $84.00 | Outperform | $00.00 00.00% ROI | |
BIIB Biogen | 4/22/2025 | Boost Price Target | $117.63 | $225.00 | Outperform | $000.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 4/14/2025 | Upgrade | $90.87 | $137.00 | Outperform | $000.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 4/11/2025 | Reiterated Rating | $6.55 | $11.00 | Outperform | $0.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 4/1/2025 | Boost Price Target | $487.06 | $420.00 | Sector Perform | $000.00 00.00% ROI | |
SRPT Sarepta Therapeutics | 3/31/2025 | Downgrade | $70.41 | $87.00 | Sector Perform | $00.00 00.00% ROI | |
MLTX MoonLake Immunotherapeutics | 3/18/2025 | Initiated Coverage | $38.67 | $67.00 | Outperform | $00.00 00.00% ROI | |
AARD Aardvark Therapeutics | 3/10/2025 | Initiated Coverage | $10.13 | $21.00 | Outperform | $0.00 00.00% ROI | |
GHRS GH Research | 3/7/2025 | Initiated Coverage | $10.55 | $31.00 | Outperform | $00.00 00.00% ROI | |
SRPT Sarepta Therapeutics | 2/27/2025 | Lower Price Target | $107.24 | $161.00 | Outperform | $00.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 2/25/2025 | Reiterated Rating | $8.11 | $11.00 | Outperform | $0.00 00.00% ROI | |
PRTA Prothena | 2/21/2025 | Lower Price Target | $15.61 | $20.00 | Sector Perform | $0.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 2/20/2025 | Boost Price Target | $475.68 | $408.00 | Sector Perform | $000.00 00.00% ROI | |
KPTI Karyopharm Therapeutics | 2/20/2025 | Reiterated Rating | $9.41 | $45.00 | Outperform | $0.00 00.00% ROI | |
BIIB Biogen | 2/13/2025 | Lower Price Target | $135.56 | $225.00 | Outperform | $000.00 00.00% ROI | |
GILD Gilead Sciences | 2/12/2025 | Boost Price Target | $103.52 | $90.00 | Sector Perform | $000.00 00.00% ROI | |
INCY Incyte | 2/11/2025 | Lower Price Target | $68.30 | $68.00 | Sector Perform | $000.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 2/11/2025 | Boost Price Target | $459.15 | $407.00 | Sector Perform | $000.00 00.00% ROI | |
PLRX Pliant Therapeutics | 2/10/2025 | Downgrade | $7.79 | $4.00 | Sector Perform | $0.00 00.00% ROI | |
KPTI Karyopharm Therapeutics | 2/10/2025 | Reiterated Rating | $9.77 | $45.00 | Outperform | $0.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 2/7/2025 | Lower Price Target | $122.00 | $148.00 | Sector Perform | $000.00 00.00% ROI | |
GILD Gilead Sciences | 2/3/2025 | Reiterated Rating | $99.12 | $84.00 | Sector Perform | $000.00 00.00% ROI | |
AXSM Axsome Therapeutics | 1/29/2025 | Reiterated Rating | $104.53 | $139.00 | Outperform | $000.00 00.00% ROI | |